A two-year extension to a one-year, multicenter, open-label, randomised study to evaluate the safety and efficacy of FTY720 combined with tacrolimus and steroids versus mycophenolate mofetyl combined with tacrolimus and steroids, in de novo adult renal transplant recipients.
Phase of Trial: Phase III
Latest Information Update: 15 Jul 2016
At a glance
- Drugs Fingolimod (Primary) ; Mycophenolate mofetil (Primary) ; Corticosteroids; Tacrolimus
- Indications Renal transplant rejection
- Focus Therapeutic Use
- Sponsors Novartis
- 31 Aug 2018 Biomarkers information updated
- 01 Nov 2011 Actual end date (Dec 2005) added as reported by ClinicalTrials.gov.
- 17 Dec 2005 New trial record.